Elisabeth Wassner-Fritsch Selected Research

Drug Therapy (Chemotherapy)

1/2017	Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma.
8/2013	Obinutuzumab (GA101) plus CHOP or FC in relapsed/refractory follicular lymphoma: results of the GAUDI study (BO21000).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elisabeth Wassner-Fritsch Research Topics

Disease

5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2020 - 10/2008
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2017 - 08/2013
1	Neoplasms (Cancer) 01/2023
1	Residual Neoplasm 01/2020
1	Disease Progression 01/2017
1	Thrombocytopenia (Thrombopenia) 08/2016
1	Neutropenia 08/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2014
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2013
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2013

Drug/Important Bio-Agent (IBA)

7	obinutuzumabIBA 02/2017 - 08/2013
6	Rituximab (Mabthera)FDA Link 01/2020 - 10/2008
3	Bendamustine Hydrochloride FDA Link 02/2017 - 08/2016
2	Monoclonal AntibodiesIBA 08/2013 - 08/2013
1	Prednisone (Sone)FDA LinkGeneric 10/2008
1	thiamine triphosphorate (TTP)IBA 10/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2008
1	Vincristine (Oncovin)FDA LinkGeneric 10/2008

Therapy/Procedure

4	Therapeutics 01/2023 - 10/2008
2	Drug Therapy (Chemotherapy) 01/2017 - 08/2013
1	Aftercare (After-Treatment) 10/2008